These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 2367600

  • 1. Urinary free cortisol levels in obsessive-compulsive disorder.
    Gehris TL, Kathol RG, Black DW, Noyes R.
    Psychiatry Res; 1990 May; 32(2):151-8. PubMed ID: 2367600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deep brain stimulation for obsessive-compulsive disorder is associated with cortisol changes.
    de Koning PP, Figee M, Endert E, Storosum JG, Fliers E, Denys D.
    Psychoneuroendocrinology; 2013 Aug; 38(8):1455-9. PubMed ID: 23333254
    [Abstract] [Full Text] [Related]

  • 7. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM.
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [Abstract] [Full Text] [Related]

  • 11. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL.
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [Abstract] [Full Text] [Related]

  • 12. The Yale-Brown Obsessive-Compulsive Scale: measures of internal consistency.
    Kim SW, Dysken MW, Pheley AM, Hoover KM.
    Psychiatry Res; 1994 Feb; 51(2):203-11. PubMed ID: 8022954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Symptom Checklist-90: Obsessive-Compulsive Subscale: A reliability and validity study.
    Kim SW, Dysken MW, Kuskowski M.
    Psychiatry Res; 1992 Jan; 41(1):37-44. PubMed ID: 1561287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HPA axis disturbance in obsessive-compulsive disorder.
    Coryell WH, Black DW, Kelly MW, Noyes R.
    Psychiatry Res; 1989 Dec; 30(3):243-51. PubMed ID: 2694203
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.